The Broad Institute Inc-Pharmaceuticals & Healthcare-Deals and Alliances Profile

The Broad Institute Inc-Pharmaceuticals & Healthcare-Deals and Alliances Profile


  • Products Id :- GDPH142286D
  • |
  • Pages: 36
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

The Broad Institute Inc (Broad Institute), a subsidiary of The Broad Foundation, is a non-profit research organization that meets critical challenges in biology and medicine. The institute transforms medicine by utilizing systematic approaches in biological sciences, to speed up the understanding and treatment of disease. It focuses on the discovery, development and optimization of technological tools that are needed to obtain and analyze massive amounts of genome-related data. The institute's projects aim to assemble a complete picture of the molecular components of life; define the biological circuits that underlie cellular responses; uncover the molecular basis of major inherited diseases; unearth all the mutations that underlie different cancer types; discover the molecular basis of major infectious diseases, and transform the process of therapeutic discovery and development. Broad Institute is headquartered in Cambridge, Massachusetts, the US.

The Broad Institute Inc-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

The Broad Institute Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

The Broad Institute Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6

The Broad Institute Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

The Broad Institute Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8

The Broad Institute Inc, Medical Devices Deals, 2011 to YTD 2017 9

The Broad Institute Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10

The Broad Institute Inc, Pharmaceuticals & Healthcare, Deal Details 12

Partnerships 12

Cohen Veterans Bioscience Partners with Stanley Center for Psychiatric Research 12

Broad Institute Genomic Services Partners with Takeda Pharma 12

Beryllium Enters into Development Agreement with Broad Institute for MCL-1 platform 13

Bayer HealthCare Expands Co-Development Agreement with Broad Institute for Cardiovascular Therapies 14

AstraZeneca Enters into Research Agreement with Broad Institute and Whitehead Institute 14

Eisai Enters into Research Agreement with Broad Institute 16

Tetra Discovery Enters Into Co-Development Agreement With Stanley Center For Schizophrenia Therapeutics 16

EMD Serono Enters Into Research Agreement With Pfizer And Broad Institute 17

Massachusetts General Hospital Enters Into Collaboration Agreement With Broad Institute And Amgen For Drug Discovery 18

Eisai Enters Into Co-Development Agreement With Broad Institute For Neglected Tropical Diseases And Tuberculosis 19

Bayer HealthCare Pharma And Broad Institute Enter Into Agreement To Develop Cancer Therapy 20

AstraZeneca And Broad Institute Partner To Advance Discovery Of Antibacterial And Antiviral Agents 22

Licensing Agreements 23

Editas Medicine Enters into Licensing Agreement with Broad Institute of Harvard and MIT, and Harvard University 23

Albany Molecular Research Enters into Licensing Agreement with Broad Institute 24

Evotec Enters into Licensing Agreement with Broad Institute 24

Transposagen Biopharma Enters into Licensing Agreement with Broad Institute 25

Neon Therapeutics Enters into Licensing Agreement with Broad Institute, Dana-Farber Cancer Institute and Massachusetts General Hospital 26

Sigma Life Science Enters into Licensing Agreement with Broad Institute for Crispr Gene Engineering System 27

GE Healthcare Life Sciences Enters into Licensing Agreement with Broad Institute for Crispr Gene Engineering System 28

Clontech Lab Enters into Licensing Agreement with Broad Institute for Crispr Gene Editing System 29

Sage Labs Enters into Licensing Agreement with Broad Institute for Crispr Gene Editing System 29

Applied Stemcell Enters into licensing Agreement with Broad Institute 30

Horizon Discovery Enters into Licensing Agreement with Broad Institute for Crispr Gene Editing System 31

The Broad Institute Inc-Key Competitors 33

Key Employees 34

Locations And Subsidiaries 35

Head Office 35

Other Locations & Subsidiaries 35

Appendix 36

Methodology 36

About GlobalData 36

Contact Us 36

Disclaimer 36

List of Figures

The Broad Institute Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1

The Broad Institute Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1

The Broad Institute Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1

The Broad Institute Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1

The Broad Institute Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

The Broad Institute Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6

The Broad Institute Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

The Broad Institute Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8

The Broad Institute Inc, Medical Devices Deals, 2011 to YTD 2017 9

List of Tables

The Broad Institute Inc, Pharmaceuticals & Healthcare, Key Facts 1

The Broad Institute Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

The Broad Institute Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6

The Broad Institute Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

The Broad Institute Inc, Deals By Therapy Area, 2011 to YTD 2017 8

The Broad Institute Inc, Medical Devices Deals, 2011 to YTD 2017 9

The Broad Institute Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10

Cohen Veterans Bioscience Partners with Stanley Center for Psychiatric Research 12

Broad Institute Genomic Services Partners with Takeda Pharma 12

Beryllium Enters into Development Agreement with Broad Institute for MCL-1 platform 13

Bayer HealthCare Expands Co-Development Agreement with Broad Institute for Cardiovascular Therapies 14

AstraZeneca Enters into Research Agreement with Broad Institute and Whitehead Institute 14

Eisai Enters into Research Agreement with Broad Institute 16

Tetra Discovery Enters Into Co-Development Agreement With Stanley Center For Schizophrenia Therapeutics 16

EMD Serono Enters Into Research Agreement With Pfizer And Broad Institute 17

Massachusetts General Hospital Enters Into Collaboration Agreement With Broad Institute And Amgen For Drug Discovery 18

Eisai Enters Into Co-Development Agreement With Broad Institute For Neglected Tropical Diseases And Tuberculosis 19

Bayer HealthCare Pharma And Broad Institute Enter Into Agreement To Develop Cancer Therapy 20

AstraZeneca And Broad Institute Partner To Advance Discovery Of Antibacterial And Antiviral Agents 22

Editas Medicine Enters into Licensing Agreement with Broad Institute of Harvard and MIT, and Harvard University 23

Albany Molecular Research Enters into Licensing Agreement with Broad Institute 24

Evotec Enters into Licensing Agreement with Broad Institute 24

Transposagen Biopharma Enters into Licensing Agreement with Broad Institute 25

Neon Therapeutics Enters into Licensing Agreement with Broad Institute, Dana-Farber Cancer Institute and Massachusetts General Hospital 26

Sigma Life Science Enters into Licensing Agreement with Broad Institute for Crispr Gene Engineering System 27

GE Healthcare Life Sciences Enters into Licensing Agreement with Broad Institute for Crispr Gene Engineering System 28

Clontech Lab Enters into Licensing Agreement with Broad Institute for Crispr Gene Editing System 29

Sage Labs Enters into Licensing Agreement with Broad Institute for Crispr Gene Editing System 29

Applied Stemcell Enters into licensing Agreement with Broad Institute 30

Horizon Discovery Enters into Licensing Agreement with Broad Institute for Crispr Gene Editing System 31

The Broad Institute Inc, Key Competitors 33

The Broad Institute Inc, Key Employees 34

The Broad Institute Inc, Other Locations 35

The Broad Institute Inc, Subsidiaries 35

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

The Broad Institute Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

select a license

Single User License
USD 250 INR 16863
Site License
USD 500 INR 33725
Corporate User License
USD 750 INR 50588

NEWSLETTER BY CATEGORY




Testimonials

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...



Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com